Purpose: colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and detection of new prognostic markers is mandatory for patients to receive optimal oncological treatment. The aim of the study was to assess clinical and prognostic value of red cell distribution width (RDW) in patients with CRC. Methods: RDW values in 90 patients with CRC undergoing surgery for primary disease were analyzed in pre-and postoperative setting, and correlated with clinical and hematological parameters. Results: Both pre-and postoperative RDW measurements were found to be associated with features of iron deficiency anemia, inflammatory response to tumor, advanced age and depth of tumor invasion. Optimal cutoff points were calculated to be 14% for preoperative and 13.6% for postoperative RDW measurements. Elevations in both pre-and postoperative RDW values had significant effects on survival in univariate and multivariate analyses. Effects were found to be independent of tumor related features, stage of the disease, development of anemia and aberrant inflammatory response to tumor. Conclusions: RDW is an integrative parameter reflecting tumor specific features and shows significant association with overall survival in patients with CRC. This is especially important in patients with stage 2 disease where elevation in preoperative RDW values can contribute to recognition of higher risk patients.
Introduction
Among all malignancies, colorectal cancer (CRC) is the third most commonly diagnosed cancer, after lung and breast cancer, with incidence of over 1.3 million and almost 700 000 deaths in 2012. 1 The projected global burden of CRC is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030, making it a significant medical problem also from the public health-point of view. 2 After initial diagnosis, some 60% of patients are treated surgically with curative intent, but 30-50% of these patients develop local or distant recurrence during follow-up. 3 Mortality of patients with recurrent and/or metastatic disease is significantly increased; however, there are still no routinely available clinical markers for precise identification of subgroups of patients with higher mortality risk.
The red cell distribution width (RDW) is a measure of variability of red blood cell volume that is reported as a part of standard complete blood count (CBC) and it represents quantitative measure of anisocytosis. Elevated RDW values are known to be associated with several types of anemias, as well as with certain liver disorders and systemic inflammation. 4 Additionally, over a past few years its elevation has also been reported as a predictor of adverse outcomes in patients with myocardial infarction (higher risk of cardiac morbidity and mortality), 5 venous thromboembolism (VTE), 6, 7 ischemic stroke, 8 cerebral infarction, after subarachnoid hemorrhage, 9 as well as in several other conditions. Some data refer to the possibility that RDW may also be a prognostic factor in patients with different types of malignant diseases, such as breast cancer, lung cancer, esophageal cancer and primary myelofibrosis. [10] [11] [12] [13] Data on prognostic value of RDW in CRC patients are scarce; however, several authors have proposed that RDW may be useful in predicting prognosis, and also help in the screening for the disease. 14, 15 This study was undertaken to assess the potential prognostic value of RDW in patients with CRC.
Materials and methods
Patients with histopathologically confirmed CRC of all stages who were initially treated surgically between March 2009 and February 2010 were included in the study. Blood samples for CBC were analyzed preoperatively (on the day of the surgical procedure for primary tumor) and postoperatively (during the 1-week period after the operation), as a part of standard procedure in patients who are surgically treated for CRC. Clinical stage of the disease was determined following the American Joint Committee on Cancer (AJCC) guidelines. 16 Patients who received any systemic treatment before both blood samples were taken were excluded from the study. Among 15 patients who initially presented with metastatic disease, 12 patients underwent only resection of the primary tumor, due to inoperable distant metastasis. Other three patients with stage IV disease underwent metastasectomy together with operation of the primary tumor. All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. During follow-up, patients were either observed or treated with systemic therapy, as to the current standard of care. With the exclusion of three patients who underwent synchronous metastasectomy and resection of the primary tumor, none of the patients underwent metastasectomy during the later course of their disease, and secondary primary tumor developed in only one patient. To evaluate potential prognostic value of preand postoperative RDW values, determined follow-up period was 3 years after surgery of the primary tumor.
Statistical analysis
Normality of data distribution was tested using KolmogorovSmirnov test. Numerical variables were represented as mean 6 standard deviation or as median and interquartile range (IQR) where appropriate. Categorical variables were represented as an absolute number and percentage. RDW values prior and after the surgery for primary disease were not normally distributed. Therefore, non-parametric tests were used to compare their relations to other variables. Numerical variables were compared using the Student's T test and the Mann-Whitney U test for independent samples and the paired sample T test and the Wilcoxon signed-rank test for paired samples where appropriate. The Kruskal-Wallis one-way analysis of variance and the Jonckheere-Terpstra trend test were used to evaluate relation of RDW values to AJCC clinical stage. The Spearman rank correlation was used to assess the correlation between numerical variables. Receiver operating characteristic (ROC) curve analysis using survival status as a classification variable was used to determine cut-off value for RDW in pre-and postoperative settings.
Survival analyses were performed using methods of Kaplan and Meier, 17 the log-rank test 18 and the Cox regression analysis.
Median follow-up was estimated using reverse Kaplan-Meier estimator. 19 Data were screened using custom made MS Excel workbook 20 and re-analyzed using MedCalc Statistical Software version 16.2.0 (MedCalc Software bvba, Ostend, Belgium). All statistical tests were two-tailed. P values < 0.05 were considered significant.
Results
There were total of 90 patients, 53 (59%) males and 37 (41%) females. The average age at the time of surgery was 66.8 6 9.7 years. Patients' clinical characteristics are shown in Table 1 . Pre-and postoperative median RDW values were 13.5% (IQR 12.6-15%) and 14% (IQR 13.1-15.9%), respectively. Pre-and postoperative RDW values differed significantly (P < 0.001).
In the preoperative settings, RDW values were significantly associated with higher age (P ¼ 0.005), lower hemoglobin level (P < 0.001), lower mean corpuscular volume (MCV) (P < 0.001), higher platelets (P < 0.001), higher absolute monocyte count (P ¼ 0.005), increased depth of tumor invasion (P ¼ 0.001) and tumor localization (median 14 vs. 13.2% for colon vs. rectum, P ¼ 0.035). Preoperative RDW values differed significantly between AJCC stages (P ¼ 0.043) ( Figure 1 ). There was a significant trend of increase in preoperative RDW values with increase in AJCC stage (P ¼ 0.009). In the postoperative setting, RDW values were significantly associated with higher age (P ¼ 0.015), lower hemoglobin level (P ¼ 0.027), lower MCV (P < 0.001), higher platelets (P ¼ 0.002), higher white blood cells (WBCs) (P ¼ 0.005), higher absolute neutrophil count (P ¼ 0.029), increased depth of tumor invasion (P ¼ 0.029) and tumor localization (median 14.4 vs. 13.6% for colon vs. rectum, P ¼ 0.024). Association of RDW with baseline AJCC clinical stage was lost postoperatively and postoperative RDW values neither differed between clinical stages nor showed a trend towards increase or decrease with higher stage of disease.
ROC curve analysis was performed for the purpose of finding an optimal cut-off for separation of patients into two groups regarding RDW values. For preoperative RDW values, optimal cut-off was set at 14%; area under the curve (AUC) was 0.704. For postoperative RDW values, optimal cut-off was set at 13.6%; AUC was 0.608. Pairwise comparison of ROC curves showed that preoperative RDW values had significantly larger AUC (P ¼ 0.022) ( Figure 1 ). There were 34 (40%) patients that had both preand postoperative RDW measurements below cutoff points, 17 (20%) patients with one measure below and one above cutoff points (16 patients with low preoperative and elevated postoperative RDW value and one patient with opposite finding) and 35 (41%) patients that had elevation in both pre-and postoperative RDW measurements.
Median follow up for overall survival (OS) was 54.4 months. The 3-year OS was 72.6% for a whole cohort of patients; median survival time was not reached. Patients with elevated preoperative RDW had inferior OS in comparison to patients with low preoperative RDW (hazard ratio (HR) 4.2; P < 0.001) (Figure 2 ). This effect was also evident in a subgroup of patients with AJCC stage 2 CRC (HR 4.5; P ¼ 0.042) (Figure 2 ). Patients with elevated postoperative RDW also showed inferior OS in comparison to patients with low postoperative RDW (HR 2.6; P ¼ 0.014) ( Figure  2 ), but the result was not significant in a subgroup of patients with AJCC stage 2 disease (HR 6; P ¼ 0.055) (Figure 2 ). When analyzing outcome regarding composite status of both pre-and postoperative measurement, we observed significant effect on survival (P < 0.001); patients with two measurements below cutoff points had same outcome as ones with one normal and one elevated measure while patients with both elevated measurements had poor prognosis.
Factors associated with OS in univariate Cox regression analysis were elevated preoperative RDW level (P < 0.001), preoperative hemoglobin level (P¼0.02), preoperative absolute monocyte count (P < 0.001), preoperative absolute eosinophil count (P ¼ 0.029), elevated postoperative RDW level (P ¼ 0.018), postoperative hemoglobin level (P ¼ 0.022), postoperative absolute monocyte count (P ¼ 0.013), postoperative absolute eosinophil count (P ¼ 0.019), depth of tumor invasion (P < 0.001), degree of spread to regional lymph nodes (P ¼ 0.003), presence of distant metastases (P < 0.001) and AJCC stage (P < 0.001). Two stepwise multivariate Cox regression models containing age, gender and univariately significant variables were created, for pre- (Table 2 ) and postoperative setting (Table 3) . In the first model, elevated preoperative RDW (P ¼ 0.008), degree of spread to regional lymph nodes (P ¼ 0.006) and presence of distant metastases (P < 0.001) remained significantly associated with OS. In the second model, elevated postoperative RDW (P ¼ 0.023), presence of distant metastases (P < 0.001) and postoperative absolute eosinophil count (P ¼ 0.013) remained significantly associated with OS. Additionally, we created two age-and gender-adjusted Cox regression models (for pre-and postoperative setting, respectively; Table 4 ) using enter method to evaluate prognostic properties of elevated RDW in comparison to AJCC clinical stage and elevated neutrophil-tolymphocyte ratio (NLR). In both models, elevated RDW (P ¼ 0.018 and P ¼ 0.028 for pre-and postoperative values, respectively) and AJCC stage (P < 0.001 in both settings) remained significantly associated with survival showing that RDW has additional prognostic properties. NLR is a wellestablished inflammatory biomarker with prognostic significance in CRC and its previously reported cutoff value of 5 was used for these analyses. 21, 22 We also investigated could elevations in pre-and postoperative RDW values predict survival independently of each other using a bivariate Cox regression model. Elevated preoperative RDW remained significantly associated with OS (P ¼ 0.01), while elevated postoperative RDW had no independent prognostic potential.
Discussion
CRC is a growing public health problem, and in order to make adequate treatment strategies, precise stratification of patients using clinical and biological markers is necessary. To the best of our knowledge, this is the first study to analyze associations of pre-and postoperative RDW values with clinical features and prognosis in patients with CRC. It was previously reported that circulating tumor cells, but also other prognostic parameters in CRC can differ in pre-and postoperative settings, thus we consider correlations of both pre-and postoperative values of potential prognostic markers with survival in CRC are mandatory. 23, 24 RDW is a part of a standard CBC and is thus widely available. [5] [6] [7] [8] [9] [10] [11] [12] [13] CRC-associated chronic blood loss can lead to development of iron deficiency anemia and consequent rise in RDW values. 25 Elevation in RDW is multifactorial in nature and cannot be attributed to iron deficiency only, since it has been shown that even non-anemic patiens have inferior survival in different diseases when they present with elevated RDW. Elevation of RDW values can reflect chronic inflammation and poor nutritional status, processes that are among the crucial ones in the tumor pathophysiology. 26 Tumor cells require suitable local environment to grow, and the effect is probably two-way-inflammatory conditions caused by mediators and cellular effectors of inflammation may occur before the malignant tumor arises, but also the tumor itself can promote chronic inflammation in its environment to amplify its growth. 27 Poor nutritional status is also recognized as an adverse factor contributing to increased morbidity and mortality, and decreased quality of life in these patients. 28, 29 The exact mechanisms of inflammation on RDW levels are unknown, but potential mechanisms include impairing iron metabolism, inhibiting the response to erythropoietin, and decreasing red blood cell survival via production of inflammatory cytokines. 30, 31 In our cohort of patients, both pre-and postoperative RDW measurements were found to be associated with features of iron deficiency anemia, inflammatory response to tumor, advanced age and depth of tumor invasion. Preoperative RDW values were more strongly associated with tumor related features (AJCC clinical stage) and aberrant inflammatory response to tumor, while postoperative RDW values were influenced by surgical procedure and were significantly higher than preoperative ones. Postoperative RDW values were associated with an increase in absolute neutrophil count, probably as a response to tissue trauma and blood loss, while associations with AJCC clinical stage and absolute monocyte count were lost.
The most striking observation was strong prognostic significance of anisocytosis in patients with CRC. Elevation in both pre and postoperative RDW values had significant associations with inferior OS. The effects on survival were found to be independent of other analyzed factors, including hemoglobin level, tumor related features, AJCC clinical stage and aberrant inflammatory response to tumor in both settings. Preoperative measurements had better prognostic properties as they were associated with survival independently of postoperative measurements. Also, preoperative RDW measurements were able to discriminate high mortality risk patients in a subgroup of patients with AJCC stage 2 disease, a subgroup of CRC patients in whom it is not always possible to identify individuals who would benefit from more intensive therapeutic approach. Also, Limitations of our study are single center data and retrograde study design. Larger prospective studies should be undertaken to confirm and further assess the association of RDW with survival of CRC patients.
In conclusion, RDW is a great integrative parameter reflecting tumor specific features and has significant association with OS in patients with CRC. In this study, prognostic effects of both pre and postoperative RDW values were found to be independent of tumor related features, AJCC prognostic score, development of anemia and aberrant inflammatory response to tumor. This makes RDW very useful prognostic parameter that is easily accessible, inexpensive and can be used in both pre-and postoperative settings.
